Get started
Author

M. Scott Lucia

Observed names: Lucia, M. Scott, MS Lucia
OpenAlex ID: A5037635520
Bardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatin
2025 · Lauren E. Thompson, Stacey M. Tuey, et al. · AAPS Open · 2
Data from Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
2023 · Kathleen Torkko, Cathee Till, et al. · 1
818 Digital Whole-Slide Inter-Observer Concordance of Contemporary Prostatic Biopsy Grading
2025 · Kenneth Iczkowski, Samuel Callis, et al. · Laboratory Investigation
Bardoxolone Methyl Demonstrates Mitigation of Cisplatin-Induced Kidney Injury in a Mouse Model with Cancer
2024 · Sarah C. Asby, Lauren E. Thompson, et al. · Journal of the American Society of Nephrology
Supplementary Data from Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
2023 · Kathleen Torkko, Cathee Till, et al.
Data from Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
2023 · Kathleen Torkko, Cathee Till, et al.
Supplementary Data from Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
2023 · Kathleen Torkko, Cathee Till, et al.
Data from Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial
2023 · Sarah H. Nash, Jeannette M. Schenk, et al.
Data from Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial
2023 · Sarah H. Nash, Jeannette M. Schenk, et al.
Supplementary Tables 1-3 from Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial
2023 · Sarah H. Nash, Jeannette M. Schenk, et al.
Supplementary Tables 1-3 from Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial
2023 · Sarah H. Nash, Jeannette M. Schenk, et al.
Finasteride and Prostate Cancer: New York Times Article from Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
2023 · Mary W. Redman, Catherine M. Tangen, et al.
Perspective from Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
2023 · Mary W. Redman, Catherine M. Tangen, et al.
Perspective from Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
2023 · Mary W. Redman, Catherine M. Tangen, et al.
Finasteride and Prostate Cancer: New York Times Article from Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
2023 · Mary W. Redman, Catherine M. Tangen, et al.
Data from Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
2023 · Mary W. Redman, Catherine M. Tangen, et al.
Data from Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
2023 · Mary W. Redman, Catherine M. Tangen, et al.
Perspective from Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
2023 · M. Scott Lucia, Amy K. Darke, et al.
Finasteride and Prostate Cancer: New York Times Article from Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
2023 · M. Scott Lucia, Amy K. Darke, et al.
Supplementary Tables 1-5 from Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial
2023 · Lauren M. Hurwitz, Ibrahim Kulac, et al.
Data from Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial
2023 · Lauren M. Hurwitz, Ibrahim Kulac, et al.
Supplementary Table 1 from Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride
2023 · James Y. Dai, Michael LeBlanc, et al.
Supplementary Figure 1 from Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride
2023 · James Y. Dai, Michael LeBlanc, et al.
Finasteride and Prostate Cancer: New York Times Article from Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
2023 · M. Scott Lucia, Amy K. Darke, et al.
Perspective from Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
2023 · M. Scott Lucia, Amy K. Darke, et al.
Works count: 40
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type